1
|
A systematic review of population screening for fragile X syndrome.
|
Genet Med
|
2010
|
1.87
|
2
|
Carrier screening for beta-thalassaemia: a review of international practice.
|
Eur J Hum Genet
|
2010
|
1.35
|
3
|
Disclosing genetic research results after death of pediatric patients.
|
JAMA
|
2008
|
1.26
|
4
|
An exploration of genetic health professionals' experience with direct-to-consumer genetic testing in their clinical practice.
|
Eur J Hum Genet
|
2012
|
1.17
|
5
|
Multimedia messages in genetics: design, development, and evaluation of a computer-based instructional resource for secondary school students in a Tay Sachs disease carrier screening program.
|
Genet Med
|
2004
|
1.00
|
6
|
A model for the development of genetics education programs for health professionals.
|
Genet Med
|
2007
|
0.98
|
7
|
Tay Sachs disease carrier screening in schools: educational alternatives and cheekbrush sampling.
|
Genet Med
|
2005
|
0.95
|
8
|
'It is not in my world': an exploration of attitudes and influences associated with cystic fibrosis carrier screening.
|
Eur J Hum Genet
|
2007
|
0.91
|
9
|
Fragile X-related element 2 methylation analysis may provide a suitable option for inclusion of fragile X syndrome and/or sex chromosome aneuploidy into newborn screening: a technical validation study.
|
Genet Med
|
2012
|
0.90
|
10
|
"It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.
|
Am J Med Genet A
|
2009
|
0.88
|
11
|
"It's about having the choice": stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome.
|
Am J Med Genet A
|
2012
|
0.87
|
12
|
Impaired response inhibition is associated with self-reported symptoms of depression, anxiety, and ADHD in female FMR1 premutation carriers.
|
Am J Med Genet B Neuropsychiatr Genet
|
2013
|
0.86
|
13
|
"It's challenging on a personal level"--exploring the 'lived experience' of Australian and Canadian prenatal genetic counselors.
|
J Genet Couns
|
2010
|
0.85
|
14
|
"Testing times, challenging choices": an Australian study of prenatal genetic counseling.
|
J Genet Couns
|
2009
|
0.84
|
15
|
Cognitive-motor interference during postural control indicates at-risk cerebellar profiles in females with the FMR1 premutation.
|
Behav Brain Res
|
2013
|
0.83
|
16
|
Key informants' perspectives of implementing chromosomal microarrays into clinical practice in Australia.
|
Twin Res Hum Genet
|
2013
|
0.82
|
17
|
Genetics and preventive health care.
|
Aust Fam Physician
|
2007
|
0.82
|
18
|
Improving family communication after a new genetic diagnosis: a randomised controlled trial of a genetic counselling intervention.
|
BMC Med Genet
|
2014
|
0.82
|
19
|
Development of a fragile X syndrome (FXS) knowledge scale: towards a modified multidimensional measure of informed choice for FXS population carrier screening.
|
Health Expect
|
2012
|
0.81
|
20
|
"Taking its toll": the challenges of working in fetal medicine.
|
Birth
|
2013
|
0.80
|
21
|
Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening.
|
Eur J Hum Genet
|
2010
|
0.80
|
22
|
Prenatal β-thalassemia carrier screening in Australia: healthcare professionals' perspectives of clinical practice.
|
Prenat Diagn
|
2014
|
0.79
|
23
|
A case for cystic fibrosis carrier testing in the general population.
|
Med J Aust
|
2011
|
0.78
|
24
|
Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: investigating why most relatives do not have testing.
|
Genet Med
|
2013
|
0.78
|
25
|
Fragile X population carrier screening.
|
Genet Med
|
2012
|
0.77
|
26
|
Development of a questionnaire for evaluating genetics education in general practice.
|
J Community Genet
|
2010
|
0.77
|
27
|
Family genetics.
|
Aust Fam Physician
|
2007
|
0.77
|
28
|
There's cancer in the family.
|
Aust Fam Physician
|
2009
|
0.76
|
29
|
Considerations for reporting genome results to patients.
|
J Paediatr Child Health
|
2013
|
0.75
|
30
|
ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible.
|
Eur J Hum Genet
|
2012
|
0.75
|
31
|
"He didn't say that thalassaemia might come up" - β-thalassaemia carriers' experiences and attitudes.
|
J Community Genet
|
2013
|
0.75
|
32
|
Responsible implementation of expanded carrier screening.
|
Eur J Hum Genet
|
2017
|
0.75
|
33
|
Why do people choose not to have screening for hemochromatosis?
|
Genet Test Mol Biomarkers
|
2012
|
0.75
|
34
|
It's "back to school" for genetic screening.
|
Eur J Hum Genet
|
2006
|
0.75
|